The Mechanism by Which Combined Exercise and Drug Therapy Modulate TGF-β/Smad2/3-regulated Lipolysis in Obese States
Science Research · 10.11.2026 · 14 (6) · 395-405
DOI: 10.11648/j.sr.20261406.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Research, online erschienen am 10.11.2026. Verfasst von Fuhui Li und 1 weiteren Autor:innen. Die Arbeit nennt 77 Literaturangaben.
Abstract (Originalsprache)
Obesity and type 2 diabetes mellitus, as major epidemiological research topics, have become global public health concerns that profoundly impact human health. According to data from the 2025 report of the National Health Commission of China, based on body mass index (BMI) and body fat percentage measurements, the prevalence of overweight among Chinese adults reached 34.3%, while the prevalence of obesity was 16.4%, yielding a combined overweight and obesity rate of 50.7%. Chronic positive energy balance, resulting from energy intake exceeding energy expenditure, leads to disruption of energy homeostasis, thereby promoting the development of chronic diseases such as obesity, type 2 diabetes, non-alcoholic fatty liver disease, and cancer. Among these, obesity and type 2 diabetes induce disorders of glucolipid metabolism and mitochondrial dysfunction, with lipid metabolic disturbances being the most prominent. This review primarily focuses on the effects of various exercise modalities combined with pharmacological interventions on adipokine profiles in obese patients or rodent models, as well as the roles of the TGF-β/Smad2/3 and AMPK/UCP1 signaling pathways in lipid metabolism. We conclude that the combination of exercise and drug therapy effectively suppresses adipokine secretion and inhibits TGF-β/Smad2/3 signaling, thereby attenuating lipogenesis, while concurrently activating the AMPK/UCP1 pathway to enhance lipolysis. Therefore, exercise combined with pharmacological treatment can effectively regulate adipokine secretion and modulate the TGF-β/Smad2/3 and AMPK/UCP1 signaling cascades, offering a promising strategy for the prevention and treatment of obesity and other metabolic disorders.
Zitieren
APA
Li, F., & Shen, W. (2026). The Mechanism by Which Combined Exercise and Drug Therapy Modulate TGF-β/Smad2/3-regulated Lipolysis in Obese States. Science Research, 14(6), 395-405. https://doi.org/10.11648/j.sr.20261406.12
Vancouver
Li F, Shen W. The Mechanism by Which Combined Exercise and Drug Therapy Modulate TGF-β/Smad2/3-regulated Lipolysis in Obese States. Science Research. 2026;14(6):395-405. doi:10.11648/j.sr.20261406.12
BibTeX
@article{Li2026,
author = {Li, Fuhui and Shen, Wenqing},
title = {The Mechanism by Which Combined Exercise and Drug Therapy Modulate TGF-β/Smad2/3-regulated Lipolysis in Obese States},
journal = {Science Research},
year = {2026},
volume = {14},
number = {6},
pages = {395--405},
doi = {10.11648/j.sr.20261406.12}
}
EUVIMED